KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.98

N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial.

Jerome Sarris, Gerard Byrne, David Castle, Chad Bousman, Georgina Oliver, Lachlan Cribb, Scott Blair-West, Vlasios Brakoulias, David Camfield, Carolyn Ee, Suneel Chamoli, Mark Boschen, Olivia M Dean, Nathan Dowling, Ranjit Menon, Jenifer Murphy, Najwa-Joelle Metri, Thomas P Nguyen, Andrew Wong, Rebecca Jordan, Diana Karamacoska, Susan L Rossell, Michael Berk, Chee H Ng

Prog Neuropsychopharmacol Biol Psychiatry 117 110550

PMID35304155
PMCID-
DOI10.1016/j.pnpbp.2022.110550
发表日期2022-03-19
入排依据:未发现恶性肿瘤人群证据。
摘要

摘要

OBJECTIVE: Preliminary evidence has suggested that adjunctive N-acetylcysteine (NAC), an antioxidant precursor to glutathione, may reduce symptoms of obsessive-compulsive disorder (OCD). We conducted a 20-week, multi-site, randomized controlled trial to investigate the safety and efficacy of the adjunctive use of NAC in OCD. METHODS: The study was a phase III, 20-week, double-blind, randomized controlled trial across multiple sites in Australia investigating 2 g to 4 g per day of NAC (titrated according to response) in 98 participants with DSM-5 diagnosed OCD. Data were analysed using linear mixed effects models for the 89 participants who attended at least one follow-up visit. RESULTS: A modified intention-to-treat analysis of the primary outcome found no evidence that NAC reduced symptoms of OCD measured on the Yale-Brown Obsessive-Compulsive Scale, relative to placebo (mean difference at week 20 = 0.53, 95% compatibility interval = -2.18, 3.23; p = 0.70; favouring placebo). There was also no evidence that NAC, compared to placebo, improved outcomes on the secondary measures including anxiety, depression, quality of life, functioning, or clinician/participant impression. NAC was well-tolerated with only mild gastrointestinal adverse events associated with the treatment. CONCLUSION: We found no evidence supporting the efficacy of the adjunctive use of NAC in OCD.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。